#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Use of latent class analysis to identify multimorbidity patterns and associated factors in Korean adults aged 50 years and older


Authors: Bomi Park aff001;  Hye Ah Lee aff003;  Hyesook Park aff001
Authors place of work: Department of Preventive Medicine, College of Medicine, Ewha Womans University, Seoul, Korea aff001;  National Cancer Control Institute, National Cancer Center, Goyang, Korea aff002;  Clinical Trial Center, Mokdong Hospital, Ewha Womans University, Seoul, Korea aff003
Published in the journal: PLoS ONE 14(11)
Category: Research Article
doi: https://doi.org/10.1371/journal.pone.0216259

Summary

Introduction

Multimorbidity associated with significant disease and economic burdens is common among the aged. We identified chronic disease multimorbidity patterns in Koreans 50 years of age or older, and explored whether such patterns were associated with particular sociodemographic factors and health-related quality-of-life.

Methods

The multimorbidity patterns of 10 chronic diseases (hypertension, dyslipidemia, stroke, osteoarthritis, tuberculosis, asthma, allergic rhinitis, depression, diabetes mellitus, and thyroid disease) were identified via latent class analysis of data on 8,370 Korean adults aged 50+ years who participated in the sixth Korean National Health and Nutrition Examination Survey (2013–2015). The associations between multimorbidity patterns, and sociodemographic factors and health-related quality of life, were subjected to regression analysis.

Results

Three patterns of multimorbidity were identified: 1) a relatively healthy group (60.4% of the population); 2) a ‘cardiometabolic conditions’ group (27.8%); and, 3) an ‘arthritis, asthma, allergic rhinitis, depression, and thyroid disease’ group (11.8%). The female (compared to male) gender was associated with an increased likelihood of membership of the cardiometabolic conditions group (odds ratio [OR] = 1.32, 95% confidence interval [CI] = 1.15–1.51) and (to a much greater extent) the arthritis, asthma, allergy, depression, and thyroid disease group (OR = 4.32, 95% CI = 3.30–5.66). Low socioeconomic status was associated with membership of the two multimorbidity classes. Membership of the arthritis, asthma, allergy, depression, and thyroid disease group was associated with a significantly poorer health-related quality-of-life than was membership of the other two groups.

Conclusion

The co-occurrence of chronic diseases was not attributable to chance. Multimorbidity patterns were associated with sociodemographic factors and quality-of-life. Our results suggest that targeted, integrated public health and clinical strategies dealing with chronic diseases should be based on an understanding of multimorbidity patterns; this would improve the quality-of-life of vulnerable multimorbid adults.

Keywords:

arthritis – Socioeconomic aspects of health – Quality of life – Allergies – Allergic rhinitis – Asthma – Thyroid

Introduction

Given aging populations, advances in medical care and public health policies, and improved living conditions, the co-occurrence of two or more chronic diseases in the same individual (multimorbidity) [1,2] is increasingly common [35]. A recent study of Koreans adults aged 50 and older found that more than one in four were multimorbid [6]. Multimorbidity is a public health concern, being associated with higher mortality, impaired functional status, a reduced quality-of-life, increased healthcare utilization, and a greater treatment burden [714]. The impact of multimorbidity can be much more complex (being synergistic) than the impact of individual diseases; health outcomes may differ by the disease combinations in play [3,15,16]. Thus, current single-disease-oriented public health strategies and clinical healthcare guidelines may be both incomplete and ineffective for multimorbid patients [17].

Certain chronic diseases tend to co-occur more often than expected by chance because they share pathophysiological pathways [18,19]. Identification of patterns of disease combinations and the characteristics of individuals exhibiting similar multimorbidity patterns may provide important information for policymakers and clinicians who seek to integrate strategic public health policy plans and healthcare management to address multimorbidity in at-risk groups more effectively. Even though multimorbidity has attracted increasing attention (because it is becoming the norm in the elderly; [17,2025]), we still do not know how multiple chronic diseases cluster, the associated socioeconomic factors, and how multimorbidity affects quality-of-life.

Multimorbidity is highly complex. The use of a statistical approach to group a population into a limited number of subgroups with similar combinations of chronic diseases is much more practical than analysis of every possible disease combination. Therefore, we performed latent class analysis (LCA) based on the hypothesis that certain chronic diseases cluster. LCA identifies probabilistic rather than deterministic subgroups based on responses to a set of observed variables, and assumes that the pattern is explained by unobserved categorical latent variables of K classes [26,27]. Our objectives were: 1) to identify multimorbidity patterns in the general Korean population aged over 50 years using nationally representative survey data; and, 2) to explore whether such patterns were associated with certain sociodemographic characteristics and quality-of-life.

Methods

Data source and sample

We used data on adults 50 years of age and older who participated in the sixth Korean National Health and Nutrition Examination Survey (KNHANES) conducted in 2013–2015. KNHANES is a cross-sectional, nationally representative survey of the noninstitutionalized Korean population conducted by the Division of Chronic Disease Surveillance, Korea Centers for Disease Control and Prevention (KCDCP). KNHANES uses a stratified, multistage cluster sampling method based on geographical area, gender, and age. The details have been described previously [28].

Measures

Chronic disease was based on self-reports, on whether participants had ever been physician-diagnosed with any disease on a pre-specified list. Analysis was limited to the 10 most common chronic diseases (hypertension, dyslipidemia, stroke, osteoarthritis, tuberculosis, asthma, allergic rhinitis, depression, diabetes mellitus, and thyroid disease; the prevalence of each is greater than 3% [2931]) of the 28 diseases listed in the KNHANES. Multimorbidity was defined as the presence of two or more of these diseases in the same subject.

The sociodemographic variables evaluated included age, gender, household income, educational level, and occupation. The household income was the monthly income divided by the square root of household size [32], and was grouped into high and low using the median income as the cut-off. Educational level was categorized as low for those younger than 70 years who were high school graduates or less accomplished, and for those older than 70 years who were middle school graduates or less accomplished. In terms of occupational status, students and housewives were defined as unemployed; service workers. retailers, agriculture or fishery employees, technicians, mechanics, assemblers, and simple laborers were defined as manual workers; and managers, professionals, and office workers were considered to be non-manual workers. The health-related quality of life was assessed using the EuroQol 5 Dimensions (EQ-5D) instrument; this is a generic measure of health status. The EQ-5D features five dimensions (mobility, self-care, engagement in usual activities, pain/discomfort, and anxiety/depression); each dimension has three response options (1 = no problem, 2 = some problems, and 3 = a severe problem). The health-related quality of life was scored as a single value (the EQ-5D index score) using a validated algorithm [33,34].

Statistical analysis

Disease prevalence, disease co-occurrence in the multimorbid, and the number of co-occurring diseases for each disease, were calculated. We used LCA to explore multimorbidity patterns. We examined one to six multimorbidity classes, and the optimal number of latent classes was determined based on the lowest Consistent Akaike Information Criterion (CAIC) and the adjusted Bayesian-Schwarz Information Criterion (adjusted BIC) [3537], clinical significance, and interpretability [38]. After selection of an optimal model, each respondent was assigned to the class for which s/he had the highest computed membership probability. An average posterior probability greater than 70% indicates an optimal fit [39]. The characteristics of respondents in different latent classes were compared using the chi-squared test for categorical variables and ANOVA for continuous variables.

After identifying latent classes, as the second step of the analysis, multinomial logistic regression was performed to assess the association between each sociodemographic factor (age, gender, household income, educational level, and occupation) and latent class membership. Associations were assessed using odds ratios (ORs) with 95% confidence intervals (CIs). Each association was adjusted in terms of the other variables in the multivariate analysis. Subsequently, as the third step of the analysis, we investigated whether health-related quality of life varied by latent class membership by a simple analysis of variance. For these analyses, we used the BCH method to yield unbiased estimates of the class differences. This approach accounts for any uncertainty introduced by classification errors when estimating the model parameters of the latent classes [40,41]. The mean of the EQ-5D index score (with the 95% CI) was estimated for each latent class. The adjusted model considered gender, age, household income, educational level, and occupation. Bonferroni post-hoc testing was performed after all pairwise comparisons. As the EQ-5D index score is not normally distributed, it was log-transformed prior to analysis and then back-transformed. All tests were two-tailed, and a p-value <0.05 was regarded as statistically significant. All statistical analyses were performed with the aid of SAS software (version 9.4; SAS Institute, Cary, NC, USA). All estimates were subjected to sample weighting to reflect the complexity of the KNHANES sampling design.

Ethics

The KNHANES was approved by the institutional review board of the Korea Centers for Disease Control and Prevention (approval nos. 2013-07CON-03-4C, 2013-12EXP-03-5C, and 2015-01-02-6C). Written informed consent was obtained from all participants.

Results

A total of 8,370 participants aged over 50 years were included in analysis. The mean age was 62.5 years, and 46% were male. Of all respondents, 39% had two or more chronic diseases; the mean number of chronic diseases in multimorbid subjects was 2.6. Table 1 lists the prevalence and the proportions of multimorbidity, and the average number of comorbid diseases for each of the 10 chronic diseases included in the analysis. Hypertension (36.4%), dyslipidemia (22.1%), osteoarthritis (19.8%), and diabetes mellitus (14.4%) were the most prevalent diseases and at least one of the 10 diseases existed as a multimorbidity in over 60% of multimorbid patients; stroke occurred in 87.1% (the highest) and tuberculosis in 63.2% (the lowest). The number of co-occurring diseases varied between 2.2 and 2.9 depending on the index disease. Table 2 summarizes the LCA model fits. When up to six latent classes were considered, the smallest adjusted BIC (two-class model: 929.18; three-class: 797.28; four-class: 801.36) and CAIC (two-class model: 1016.91; three-class: 930.97; four-class: 981.01) were those of the three-class model; these classes were labelled relatively healthy, those with cardiometabolic conditions, and those with arthritis, asthma, allergic rhinitis, depression, and thyroid disease as revealed by the estimated probabilities of any particular chronic disease given membership of a latent class. Every respondent was assigned to one of the three classes based on the highest membership probability. The relatively healthy group included those with a low prevalence of all evaluated chronic conditions. The cardiometabolic conditions group was populated by those with high probabilities of hypertension, dyslipidemia, stroke, and diabetes mellitus. The latent class proportions were 60.4%, 27.8%, and 11.8% respectively (Table 3). The total proportion of classification error is 22% which is acceptable [39]. The mean age of the cardiometabolic conditions group was the highest (67 years). Both the cardiometabolic conditions group (40.2% male vs. 59.8% female) and the arthritis, asthma, allergy, depression, and thyroid disease group had higher proportions of females (17.7 vs. 82.3%); males constituted over 50% of the relatively healthy group (51.4 vs. 48.6%). In particular, most subjects were female in the arthritis, asthma, allergy, depression, and thyroid disease group (82.3%). Socioeconomic status was similar in the cardiometabolic conditions group and the arthritis, asthma, allergy, depression, and thyroid disease group; both groups evidenced higher proportions (compared to the overall figures) of individuals with lower household incomes, lower levels of education, and of unemployed status. The mean number of co-occurring chronic conditions was highest (2.9) in the arthritis, asthma, allergy, depression, and thyroid disease group (Table 4).

Tab. 1. The prevalence and characteristics of certain chronic diseases in 8,370 KNHANES 2013–2015 respondents aged 50 years and older.
The prevalence and characteristics of certain chronic diseases in 8,370 KNHANES 2013–2015 respondents aged 50 years and older.
Tab. 2. A Comparison of the fit statistics of models featuring latent class analyses.
A Comparison of the fit statistics of models featuring latent class analyses.
Tab. 3. Class membership and item response probabilities of the three latent classes.
Class membership and item response probabilities of the three latent classes.
Tab. 4. Characteristics of study respondents by latent class membership.
Characteristics of study respondents by latent class membership.

A multinomial logistic regression analysis adjusted for age, gender, educational level, household income, and occupation showed that age increased the risk of being in one of the multimorbid groups—particularly the cardiometabolic conditions group—compared to the relatively healthy group. The risk of being in the cardiometabolic conditions group was higher for subjects in their 60s (OR = 3.08, 95% CI = 2.60–3.65), 70s (OR = 4.13, 95% CI = 3.44–4.95), and ≥ 80s (OR = 3.16, 95% CI = 2.39–4.19) compared to those in their 50s. The risk of being in the arthritis, asthma, allergy, depression, and thyroid disease group was higher for subjects in their 60s (OR = 1.98, 95% CI = 1.57–2.49) and 70s (OR = 1.54, 95% CI = 1.16–2.04) compared to those in their 50s, but no difference was found between subjects in their 50s and ≥ 80s. The risks of membership of the cardiometabolic conditions group (OR = 1.32, 95% CI = 1.15–1.51) and the arthritis, asthma, allergy, depression, and thyroid disease group (OR = 4.32, 95% CI = 3.30–5.66) were significantly higher for females than males. Lower household income (OR = 1.32, 95% CI = 1.14–1.52) and lower educational level (OR = 1.25, 95% CI = 1.05–1.49) significantly increased the risk of membership of the cardiometabolic conditions group. In addition, employed status decreased the risk of membership of both the cardiometabolic conditions group and the arthritis, asthma, allergy, depression, and thyroid disease group (Table 5).

Tab. 5. Sociodemographic factors of the latent classes as revealed by multinomial logistic regression.
Sociodemographic factors of the latent classes as revealed by multinomial logistic regression.

Table 6 shows the association between class membership and health-related quality-of-life. When the means of the health-related quality-of-life of the latent classes were compared after adjustment for age, gender, household income, educational level, and occupation, individuals in the arthritis, asthma, allergy, depression, and thyroid disease group evidenced a significantly lower health-related quality-of-life (0.81) than the other two groups (0.97 for the relatively healthy group; 0.90 for the cardiometabolic conditions group) as revealed by Bonferroni post-hoc analysis for multiple comparisons.

Tab. 6. Associations between multimorbidity patterns and EQ-5D index scoresa.
Associations between multimorbidity patterns and EQ-5D index scores<em class="ref"><sup>a</sup></em>.

Discussion

We used LCA to identify three distinct multimorbidity patterns in the general Korean population: (1) a relatively healthy group; (2) a group with cardiocerebrovascular conditions including hypertension, dyslipidemia, stroke, and diabetes mellitus; and, (3) a group with arthritis, asthma, allergic rhinitis, depression, and thyroid disease. Our analysis not only indicated what other diseases were likely to co-occur in subjects with certain diseases but also allowed us to explore whether individuals with certain sociodemographic characteristics were more vulnerable to multimorbidity and the associated adverse health outcomes in terms of health-related quality of life.

It is difficult to directly compare our results to those of previous studies given the methodological differences in terms of study setting, disease spectrum and number, demographic factors, baseline health status of participants, and the statistical methods used [29], but the multimorbidity patterns we identified are in general agreement with those of prior works. Such similarities may indicate that chronic diseases aggregate because they share underlying risk factors (so one disease increases the risk of another) or that causalities are shared [19].

We found that hypertension, dyslipidemia, stroke, and diabetes mellitus were very likely to co-occur, as have several prior studies evaluating subjects with (predominantly) cardiocerebrovascular conditions [17,19,21,4244]. In this study, the dyslipidemia response probabilities were very similar for the two multimorbid groups but dyslipidemia was classified as a cardiometabolic condition based on the clinical nature of the disease. It is known that hypertension, dyslipidemia, and diabetes mellitus are risk factors for cerebrovascular diseases, and may precede such diseases [4548].

Although the mechanism behind the combination of arthritis, asthma, allergic rhinitis, depression, and thyroid disease remains unclear, similar groupings were evident in other studies. Arthritis and depression were co-grouped by Simoes et al. [19], asthma and allergy by Larsen et al. [49], and arthritis, asthma, and psychiatric symptoms formed a latent class in the work of Islam [17,44]. Thyroid function was strongly associated with neuropsychological function [50], the development or exacerbation of asthma [51,52], and progression of osteoarthritis [53].

We found that older age, being female, and lower socioeconomic status increased the risk of membership of the cardiometabolic conditions group and/or the arthritis, asthma, allergy, depression, and thyroid disease group, as compared to the relatively healthy group. Being in the older age groups increased the risk of being in the cardiometabolic conditions group three- to four-fold, but the pattern of arthritis, asthma, allergy, depression and thyroid disease was less dependent on age. This finding suggests that older people should be approached cautiously due to the possibility of multimorbidity with cardiometabolic conditions.

The arthritis, asthma, allergy, depression, and thyroid disease group were more strongly associated with a lower quality of life than the cardiometabolic condition group, although the quality of life was significantly lower in both multimorbidity groups compared to the relatively healthy group. Our previous study, based on participants 50 years and older from the same survey, found that the EQ-5D index score of patients with one of hypertension, diabetes mellitus, or dyslipidemia was 0.92, and that for patients with osteoarthritis only it was 0.83. These scores are similar to the EQ-5D index scores for the second and third patterns, respectively, in the present study. Therefore, the EQ-5D index score for the pattern reflects the impact of its constituent diseases on quality of life. The combination of diseases in the arthritis, asthma, allergy, depression, and thyroid disease group was strongly associated with more sensitive pain perception, physical limitation, functional impairment in daily activity, and quality of life in other works [19, 54], supporting our findings.

In addition, being female increased the risk of membership of the arthritis, asthma, allergy, depression, and thyroid disease group more than four-fold, and the female predominance in a musculoskeletal class and a headache-mental illness class was noted by Larsen et al. [49] as well. In addition, individuals assigned to this latent class had a lower quality-of-life. Therefore, females are significantly more likely to develop the disease cluster of arthritis, asthma, allergy, depression, and thyroid disease than males and so experience a lower quality of life for their remaining lifespan. Such gender inequality in healthy life expectancy caused by multimorbidity warrants public health interventions targeting the female elderly.

Multimorbidity is increasingly common; and current clinical practice guidelines, which focus on a single disease, are not responsive to the complex health care needs of multimorbidity. Our findings suggest the necessity of developing targeted prevention and treatment healthcare strategies that take the pattern of multiple chronic diseases into consideration. Given the cross-sectional association between multimorbidity pattern and health-related quality of life found in this study, it is possible that targeted efforts to prevent and manage the multimorbid patient will exert a positive effect on the health-related quality of life of patients with multiple diseases. In addition, given the existence of groups vulnerable to certain combinations of diseases, additional interventions are warranted in this vulnerable population.

Most previous studies on multimorbidity used a non-model approach such as counts of the most common disease combinations and their observed-to-expected ratios [5557]; such methods are too simplistic. Recently, several studies have used statistical approaches such as cluster analysis [31,58,59], factor analysis [21,25,42,43], and LCA [17,22,36,44,6062] to identify nonrandom multimorbidity clusters. We used LCA to identify subgroups based on structural equation modeling [63]. LCA is better than conventional clustering because LCA employs probability-based classification methods to choose an optimal number of classes based on various diagnostic tests [27,64]. This allowed us to group individuals into a limited number of latent classes and then analyze the differences between the classes.

Our study had certain limitations. Our study is based on limited number of chronic diseases with a prevalence of ≥ 3% recorded by the KNHANES. Previous studies that used latent class analysis also applied a prevalence cut-off for inclusion of 2–10% [17, 22, 30, 65, 66]. Other studies that applied different statistical techniques also established a minimal prevalence for the inclusion [29]. However, the pattern might have been different if greater number of diseases were included, so we additionally conducted an analysis that included 25 chronic diseases listed in the KNHANES. However, inclusion of diseases with a prevalence of < 3% did not change the class structure of the 10 originally included chronic diseases. Moreover, the response probabilities for the newly included diseases were too small to decide in which category each disease should be included. When we included a further six chronic diseases (all cancers combined, myocardial infarction, angina, rheumatic arthritis, renal failure, and atopic dermatitis) in addition to the 10 originally included chronic diseases in the LCA, the class structure was unchanged from the original pattern. Second, we only considered disease occurrence and, thus, not duration or severity. Finally, we cannot discuss causal relationships between diseases because the survey was cross-sectional in nature. However, using a large and nationally representative sample, we identified multimorbidity patterns, and associations between such patterns and both sociodemographic factors and health-related quality-of-life.

Conclusion

This study demonstrates that there are distinct subgroups of patients with specific patterns of multimorbidity. Also, individuals of the three classes exhibited different sociodemographic characteristics and varied in terms of health-related quality of life. Our findings deepen our understanding of non-random associations between diseases; this will aid the design of timely, useful, effective, holistic healthcare and preventative strategies addressing the needs of multimorbid individuals and those at high risk of multimorbidity. In addition, given that the multimorbidity patterns are associated with poor quality-of-life and sociodemographic inequalities, targeted multimorbidity management is important to reduce the burden on the vulnerable population and to address the associated social inequalities.


Zdroje

1. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3: 223–228. doi: 10.1370/afm.272 15928225

2. van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity. Eur J Gen Pract. 1996;2: 65–70.

3. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7: 357–363. doi: 10.1370/afm.983 19597174

4. Parekh AK, Goodman RA, Gordon C, Koh HK. Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life. Public Health Rep. 2011;126: 460–471. doi: 10.1177/003335491112600403 21800741

5. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380: 37–43. doi: 10.1016/S0140-6736(12)60240-2 22579043

6. Park B, Ock M, Lee HA, Lee S, Han H, Jo MW, et al. Multimorbidity and health-related quality of life in Koreans aged 50 or older using KNHANES 2013–2014. Health Qual Life Outcomes. 2018;16: 186. doi: 10.1186/s12955-018-1016-6 30219061

7. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2: 51–51. doi: 10.1186/1477-7525-2-51 15380021

8. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61: e12–21. doi: 10.3399/bjgp11X548929 21401985

9. Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350: h176. doi: 10.1136/bmj.h176 25646760

10. Lehnert T, Heider D, Leicht H, Heinrich S, Corrieri S, Luppa M, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev. 2011;68: 387–420. doi: 10.1177/1077558711399580 21813576

11. Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois MF, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006;15: 83–91. doi: 10.1007/s11136-005-8661-z 16411033

12. Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens EJ, Kromhout D. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol. 2001;54: 680–686. doi: 10.1016/s0895-4356(00)00368-1 11438408

13. Librero J, Peiro S, Ordinana R. Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol. 1999;52: 171–179. doi: 10.1016/s0895-4356(98)00160-7 10210233

14. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162: 2269–2276. doi: 10.1001/archinte.162.20.2269 12418941

15. McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Pol. 2016;9: 143–156.

16. Starfield B. Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med. 2006;4: 101–103. doi: 10.1370/afm.524 16569711

17. Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS One. 2014;9: e83783. doi: 10.1371/journal.pone.0083783 24421905

18. Kessler R. Comorbidity. Amsterdam, NY: Elsevier Science Ltd; 2001.

19. Simoes D, Araujo FA, Severo M, Monjardino T, Cruz I, Carmona L, et al. Patterns and consequences of multimorbidity in the general population: there is no chronic disease management without rheumatic disease management. Arthritis Care Res (Hoboken). 2017;69: 12–20.

20. García-Olmos L, Salvador CH, Alberquilla Á, Lora D, Carmona M, García-Sagredo P, et al. Comorbidity patterns in patients with chronic diseases in general practice. PLoS One. 2012;7: e32141. doi: 10.1371/journal.pone.0032141 22359665

21. Schafer I, von Leitner EC, Schon G, Koller D, Hansen H, Kolonko T, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2010;5: e15941. doi: 10.1371/journal.pone.0015941 21209965

22. Kuwornu JP, Lix LM, Shooshtari S. Multimorbidity disease clusters in Aboriginal and non-Aboriginal Caucasian populations in Canada. Chronic Dis Inj Can. 2014;34: 218–225. 25408181

23. Cornell J, Pugh J, Williams J, Kazis L, Lee A, Parchman M, et al. Multimorbidity clusters: clustering binary data from multimorbidity clusters: clustering binary data from a large administrative medical database. Appl Multivar Res. 2009;12: 163–182.

24. Poblador-Plou B, van den Akker M, Vos R, Calderón-Larrañaga A, Metsemakers J, Prados-Torres A. Similar multimorbidity patterns in primary care patients from two European regions: results of a factor analysis. PLoS One. 2014;9: e100375. doi: 10.1371/journal.pone.0100375 24956475

25. Prados-Torres A, Poblador-Plou B, Calderon-Larranaga A, Gimeno-Feliu LA, Gonzalez-Rubio F, Poncel-Falco A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One. 2012;7: e32190. doi: 10.1371/journal.pone.0032190 22393389

26. Kongsted A, Nielsen AM. Latent class analysis in health research. J Physiother. 2017;63: 55–58. doi: 10.1016/j.jphys.2016.05.018 27914733

27. Vermunt J, Magindson J. Latent class cluster analysis. In: Hagenaars J, McCutcheon A, editors. Applied latent class analysis. Cambridge: Cambridge University Press; 2002. pp. 89–106.

28. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea national health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43: 69–77. doi: 10.1093/ije/dyt228 24585853

29. Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67: 254–266. doi: 10.1016/j.jclinepi.2013.09.021 24472295

30. Hussain MA, Katzenellenbogen JM, Sanfilippo FM, Murray K, Thompson SC. Complexity in disease management: a linked data analysis of multimorbidity in aboriginal and non-Aboriginal patients hospitalised with atherothrombotic disease in Western Australia. PLoS One. 2018;13: e0201496. doi: 10.1371/journal.pone.0201496 30106971

31. Marengoni A, Rizzuto D, Wang HX, Winblad B, Fratiglioni L. Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc. 2009;57: 225–230. doi: 10.1111/j.1532-5415.2008.02109.x 19207138

32. OECD. Terms of Reference OECD Project on the Distribution of Household Incomes. 2018. 20 August 2018. Available from: http://www.oecd.org/els/soc/IDD-ToR.pdf.

33. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12: 1187–1193. doi: 10.1111/j.1524-4733.2009.00579.x 19659703

34. Kim MH, Cho YS, Uhm WS, Kim S, Bae SC. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res. 2005;14: 1401–1406. doi: 10.1007/s11136-004-5681-z 16047514

35. Akaike H. A new look at the statistical model identification. IEEE Trans Autom. 1974;19: 716–723.

36. Schwarz G. Estimating the dimension of a model. Ann Statist. 1978;6: 461–464.

37. Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a monte carlo simulation study. Struct Equ Model Multidiscip J. 2007;14: 535–569.

38. Masyn K. Latent class analysis and finite mixture modeling. In: Little T, editor. The Oxford handbook of quantitative methods in psychology. New York: Oxford University Press; 2013. pp. 551–611.

39. Nagin D. Group-based modeling of development. Cambridge, MA: Harvard University Press; 2005.

40. Nylund-Gibson K. & Choi AY. Ten Frequently Asked Questions About Latent Class Analysis. American Psychological Association. 2018;4: 440–461

41. Asparouhov T & Muthén BO. Auxiliary variables in mixture modeling: Three-step approaches using Mplus. Structural Equation Modeling, 2014;21: 329–341.

42. Holden L, Scuffham PA, Hilton MF, Muspratt A, Ng SK, Whiteford HA. Patterns of multimorbidity in working Australians. Popul Health Metr. 2011;9: 15. doi: 10.1186/1478-7954-9-15 21635787

43. Kirchberger I, Meisinger C, Heier M, Zimmermann AK, Thorand B, Autenrieth CS, et al. Patterns of multimorbidity in the aged population. Results from the KORA-age study. PLoS One. 2012;7: e30556. doi: 10.1371/journal.pone.0030556 22291986

44. Whitson HE, Johnson KS, Sloane R, Cigolle CT, Pieper CF, Landerman L, et al. Identifying patterns of multimorbidity in older americans: application of latent class analysis. J Am Geriatr Soc. 2016;64: 1668–1673. doi: 10.1111/jgs.14201 27309908

45. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121: 293–298. doi: 10.1016/0002-8703(91)90861-b 1985385

46. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365: 434–441. doi: 10.1016/S0140-6736(05)17833-7 15680460

47. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102: 3137–3147. doi: 10.1161/01.cir.102.25.3137 11120707

48. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129: e28–e292. doi: 10.1161/01.cir.0000441139.02102.80 24352519

49. Larsen FB, Pedersen MH, Friis K, Glumer C, Lasgaard M. A latent class analysis of multimorbidity and the relationship to socio-demographic factors and health-related quality of life. A national population-based study of 162,283 Danish adults. PLoS One. 2017;12: e0169426. doi: 10.1371/journal.pone.0169426 28056050

50. Feldman AZ, Shrestha RT, Hennessey JV. Neuropsychiatric manifestations of thyroid disease. Endocrinol Metab Clin North Am. 2013; 42:453–76. doi: 10.1016/j.ecl.2013.05.005 24011880

51. Bingyan Z, Dong W. Impact of thyroid hormones on asthma in older adults. J Int Med Res. 2019;47(9): 4114–4125. doi: 10.1177/0300060519856465 31280621

52. Przybyłowski J, Piestrak J, Kowalski D. Triiodothyronine (T3) and thyroxine (T4) levels in patients with bronchial asthma. Wiad Lek. 1989;42: 20–24. 2781800

53. Hossain F, Hong Y, Jin Y, Choi J, Hong Y. Physiological and Pathological Role of Circadian Hormones in Osteoarthritis: Dose-Dependent or Time-Dependent? J. Clin. Med. 2019;8(9), 1415

54. Loza E, Jover JA, Rodriguez L, Carmona L. Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin Arthritis Rheum. 2009;38:312–9. doi: 10.1016/j.semarthrit.2008.01.004 18336872

55. Freund T, Kunz CU, Ose D, Szecsenyi J, Peters-Klimm F. Patterns of multimorbidity in primary care patients at high risk of future hospitalization. Popul Health Manag. 2012;15: 119–124. doi: 10.1089/pop.2011.0026 22313440

56. Wong A, Boshuizen HC, Schellevis FG, Kommer GJ, Polder JJ. Longitudinal administrative data can be used to examine multimorbidity, provided false discoveries are controlled for. J Clin Epidemiol. 2011;64: 1109–1117. doi: 10.1016/j.jclinepi.2010.12.011 21454049

57. van den Bussche H, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G, et al. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health. 2011;11: 101. doi: 10.1186/1471-2458-11-101 21320345

58. John R, Kerby DS, Hennessy CH. Patterns and impact of comorbidity and multimorbidity among community-resident American Indian elders. Gerontologist. 2003;43: 649–660. doi: 10.1093/geront/43.5.649 14570961

59. Newcomer SR, Steiner JF, Bayliss EA. Identifying subgroups of complex patients with cluster analysis. Am J Manag Care. 2011;17: e324–e332. 21851140

60. Schüz B, Wurm S, Warner LM, Tesch-Römer C. Health and subjective well-being in later adulthood: different health states—different needs? Appl Psychol Health Well Being. 2009;1: 23–45.

61. Pugh MJ, Finley EP, Copeland LA, Wang CP, Noel PH, Amuan ME, et al. Complex comorbidity clusters in OEF/OIF veterans: the polytrauma clinical triad and beyond. Med Care. 2014;52: 172–181. doi: 10.1097/MLR.0000000000000059 24374417

62. Swartz JA. Chronic medical conditions among jail detainees in residential psychiatric treatment: a latent class analysis. J Urban Health. 2011;88: 700–717. doi: 10.1007/s11524-011-9554-9 21394659

63. Hagenaars J, McCutcheon A. Applied latent class analysis. Cambridge, New York: Cambridge University Press; 2009.

64. Magidson J, Vermunt J. Latent class models for clustering: a comparison with K-means. Can J Market Res. 2002;20: 37–44.

65. Swartz JA, Ducheny K, Holloway T, Stokes L, Willis S, Kuhns LM. A Latent Class Analysis of Chronic Health Conditions Among HIV-Positive Transgender Women of Color. AIDS Behav. 2019 May 29. [Epub ahead of print]

66. Hesketh KR, Fagg J, Muniz-Terrera G, Bedford H, Law C, Hope S. Cooccurrence and clustering of health conditions at age 11: cross-sectional findings from the Millennium Cohort Study. BMJ Open 2016;6:e012919 doi: 10.1136/bmjopen-2016-012919 27881529


Článek vyšel v časopise

PLOS One


2019 Číslo 11
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#